Factor | Lin2017 (10039)

10.1016/j.jgar.2017.05.010

Ceftiofur use

Swine | Weaners

11

Description

Piglets were subjected to parenteral administration of a sub-therapeutic dosage of ceftiofur (Naxcel) at 0.5 mg/kg BW (body weight) parenterally once daily during a three days’ treatment period.

Resistance Outcomes

Resistance Microbe Outcome
Cefotaxime
/
Escherichia coli
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Ceftiofur use 20.00 50
No use 0.00 50
Ciprofloxacin
/
Escherichia coli
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Ceftiofur use 5.00 50
No use 0.00 50
Kanamycin
/
Escherichia coli
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Ceftiofur use 65.00 50
No use 15.00 50
Ceftriaxone
/
Escherichia coli
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Ceftiofur use 10.00 50
No use 0.00 50
Tetracycline
/
Escherichia coli
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Ceftiofur use 95.00 50
No use 100.00 50
Chloramphenicol
/
Escherichia coli
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Ceftiofur use 15.00 50
No use 75.00 50
Nalidixic Acid
/
Escherichia coli
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Ceftiofur use 40.00 50
No use 80.00 50
Gentamicin
/
Escherichia coli
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Ceftiofur use 0.00 50
No use 5.00 50
See Gene Column CTX-M-1 (ARO:3001864)
/
Escherichia coli
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Ceftiofur use 0.00 50
No use 6.00 50
See Gene Column CTX-M-2 (ARO:3001865)
/
Escherichia coli
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Ceftiofur use 0.00 50
No use 0.00 50
See Gene Column CTX-M-9 (ARO:3001872)
/
Escherichia coli
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Ceftiofur use 35.00 50
No use 43.00 50